Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001842952-25-000008
Filing Date
2025-01-14
Accepted
2025-01-14 20:36:50
Documents
2
Period of Report
2025-01-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1736905004.html 3  
1 FORM 3 wk-form3_1736905004.xml 3 1633
2 EX-24 context-andypasternaksecti.htm EX-24 7782
  Complete submission text file 0001842952-25-000008.txt   11039
Mailing Address C/O HORIZON THERAPEUTICS PLC CONNAUGHT HOUSE, 1ST FL, 1 BURLINGTON RD DUBLIN L2 D04 C5Y6
Business Address
Pasternak Andy (Reporting) CIK: 0001792746 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40654 | Film No.: 25530746

Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 863738787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)